✦ LIBER ✦

The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The advance trial

✍ Scribed by Marco Valgimigli; Gianfranco Percoco; Dario Barbieri; Fabrizio Ferrari; Gabriele Guardigli; Giovanni Parrinello; Olga Soukhomovskaia; Roberto Ferrari

Book ID: 119264156
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 105 KB
Volume: 44
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.03.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The additive value of tirofiban administ

The additive value of tirofiban administered with a high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The ADVANCE Trial

✍ M. Valgimigli; G. Percoco; D. Barbieriet 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Randomized Comparison of Upstream Tirofi

Randomized Comparison of Upstream Tirofiban Versus Downstream High Bolus Dose Tirofiban or Abciximab on Tissue-Level Perfusion and Troponin Release in High-Risk Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions: The EVEREST Trial

✍ Leonardo Bolognese; Giovanni Falsini; Francesco Liistro; Paolo Angioli; Kenneth 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 201 KB

A randomized two-by-two comparison of hi

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial

✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

Inhibition of the sodium-hydrogen exchan

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations main results of the guard during ischemia against necrosis (GUARDIAN) trial

✍ P Théroux; B.R Chaitman; N Danchin 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Short-Term, High-Dose Atorvastatin Pretr

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB

High-dose atorvastatin and risk of atria

High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Gregory G. Schwartz; Bernard R. Chaitman; Jeffrey J. Goldberger; Michael Messig 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB